TITLE

Cystic fibrosis treatment responses and consequences

PUB. DATE
December 2007
SOURCE
Thorax;Dec2007 Supp, Vol. 62, pA30
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts on medical topics which include the results of a cystic fibrosis (CF) gene therapy consortium tracking study in Great Britain, serial change and observer agreement of computed tomography in infective exacerbations in CF and functional and structural changes in the CF lung after antibiotic treatment for exacerbation.
ACCESSION #
27950439

 

Related Articles

  • Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Horsley, A. R.; Gustafsson, P. M.; Macleod, K. A.; Saunders, C.; Greening, A. P.; Porteous, D. J.; Davies, J. C.; Cunningham, S.; Alton, E. W. F. W.; Innes, J. A. // Thorax;Feb2008, Vol. 63 Issue 2, p135 

    Background: Lung clearance index (LCI) is a sensitive marker of early lung disease in children but has not been assessed in adults. Measurement is hindered by the complexity of the equipment required. The aims of this study were to assess performance of a novel gas analyser (Innocor) and to use...

  • Cystic fibrosis: Big unmet needs, small steps. Savopoulos, John; Oversteegen, Lisette // Journal of Medical Marketing;Jul2006, Vol. 6 Issue 3, p158 

    Cystic fibrosis (CF) is a genetic disease that causes the respiratory mucus to be thinker than normal. Although CF patients have a variety of symptoms, congested lungs and impaired breathing are the most important. The treatment of CF includes the prescription of mucolytics, antibiotics and...

  • Gene therapy for children with cystic fibrosis--who has the right to choose? Jaffé, A.; Prasad, S. A.; Larcher, V.; Hart, S. // Journal of Medical Ethics;Jun2006, Vol. 32 Issue 6, p361 

    The article discusses issues related to gene therapy for children with cystic fibrosis (CF). CF is described as a life limiting illness with high morbidity that imposes considerable burdens on children and families. The results of the pathophysiological features of CF are discussed, including...

  • Gene therapy: the case for cystic fibrosis. Alton, Eric WFW; Geddes, Duncan // Journal of the Royal Society of Medicine (Supplement);Feb1997, Vol. 90 Issue 31, p43 

    The article discusses a study which investigated the use of gene therapy in the treatment of cystic fibrosis. The study suggested that liposome-mediated cystic fibrosis transmembrane conductance regulator gene transfer may be a practical option for initial studies of gene transfer into cystic...

  • Gene therapy in cystic fibrosis. Armstrong, David K.; Cunningham, Steve; Davies, Jane C.; Alton, Eric W. F. W. // Archives of Disease in Childhood;May2014, Vol. 99 Issue 5, p465 

    The principal cause of morbidity and mortality in cystic fibrosis (CF) is pulmonary disease, so the focus of new treatments in this condition is primarily targeted at the lungs. Since the cloning of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene in 1989, there has been...

  • Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis. Pedersen, Maya Graham; Jensen-Fangel, Søren; Olesen, Hanne Vebert; Tambe, San deep Prataprao; Petersen, Eskild // BMC Infectious Diseases;Jul2015, Vol. 15 Issue 1, p1 

    Background: To determine complications during outpatient parenteral antimicrobial therapy (OPAT) administrated through a peripheral venous line, PICC-line or PORT-A-CATH (PAC). Methods: Catheter related complications in patients with cystic fibrosis during OPAT were identified through a...

  • CITATIONS AND CLINICIANS' NOTES: CYSTIC FIBROSIS.  // Current Medical Literature: Respiratory Medicine;2004, Vol. 18 Issue 1, p26 

    Presents citations and clinicians' notes on studies on cystic fibrosis. "Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL," by N. Reinhardt, et al; "Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease,"...

  • 'To CT or not to CT? That is the question': outcome surrogates for surveillance in childhood cystic fibrosis. Young, Carolyn; Owens, Catherine // Thorax;Jun2012, Vol. 67 Issue 6, p471 

    The author reflects on the use of computerized tomography (CT) for the monitoring of the patients especially children with cystic fibrosis (CF) who suffer from lung diseases. The use of thin section CT with respect to the imaging modality is highlighted by a study conducted by the Australian...

  • Computed tomography dose and variability of airway dimension measurements: how low can we go? de Jong, Pim A.; Long, Frederick R.; Nakano, Yasutaka // Pediatric Radiology;Oct2006, Vol. 36 Issue 10, p1043 

    Background: Quantitative CT shows promise as an outcome measure for cystic fibrosis (CF) lung disease in infancy, but must be accomplished at a dose as low as reasonably achievable.Objective: To determine the feasibility of ultra-low-dose CT for quantitative...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics